Overdiagnosis in the Age of Digital Cancer Screening

Otis W Brawley^{1

2}, Channing J Paller^{3

4}

Affiliations

¹ Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
² Department of Epidemiology, Bloomberg School of Public Health, Baltimore, MD, USA.
³ Department of Oncology, Johns Hopkins School of Medicine , Baltimore, MD, USA.
⁴ Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Editorial

Otis W Brawley et al. J Natl Cancer Inst. 2021.

. 2021 Jan 4;113(1):1-2.

doi: 10.1093/jnci/djaa081.

Otis W Brawley^{1

2}, Channing J Paller^{3

4}

¹ Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
² Department of Epidemiology, Bloomberg School of Public Health, Baltimore, MD, USA.
³ Department of Oncology, Johns Hopkins School of Medicine , Baltimore, MD, USA.
⁴ Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD, USA.

No abstract available

References

1. Farber R, Houssami N, Wortley S, et al.Impact of full-field digital mammography versus film-screen mammography: a systematic review and meta-analysis. J Natl Cancer Inst. 2021;113(1):16–26. - PMC - PubMed
1. Autier P, Boniol M, Koechlin A, Pizot C, Boniol M.. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. BMJ. 2017;359:j5224. - PMC - PubMed
1. Welch HG, Gorski DH, Albertsen PC.. Trends in metastatic breast and prostate cancer--lessons in cancer dynamics. N Engl J Med. 2015;373(18):1685–1687. - PubMed
1. Andre F, Ismalia N, Henry NL, et al.Use of biomarkers to guide decision on adjuvant systemic therapy for women with early-stage invasive breast cancer: ASCO clinical practice guideline update-integration of results from TAILORx. J Clin Oncol. 2019;37(22):1956–1964. - PubMed